Page 28 - Medication Guide News Today

KEYTRUDA is approved for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors, as determined by an FDA-approved test, that have progressed... | March 29, 2023

Sotyktu demonstrated superior efficacy in improving skin clearance over placebo and twice-daily Otezla® , with a well-tolerated safety profile, in the pivotal Phase 3 POETYK PSO clinical... | March 28, 2023

KEYTRUDA plus chemotherapy reduced risk of disease progression or death by 46% in patients whose cancer was mismatch repair proficient and by 70% in patients whose cancer was mismatch repair... | March 27, 2023

Total revenues of €361.3 million in 2022 compared to €348.1 million in 2021 Driven by product sales of €114.8 million (82.3% increase compared to 2021), including €85.2 million of travel vaccine sales

EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada. MAVENCLAD is a registered trademark of Merck KGaA, Darmstadt, Germany or its affiliates...

Treatment with SKYRIZI (risankizumab) demonstrated short- and long-term efficacy of psoriasis signs and symptoms (sPGA 0/1) at week 16 and week 52 in a...

/PRNewswire/ -- Danco Laboratories forcefully defended the approval of Mifeprex® in a four-hour hearing held in federal court in Amarillo, Texas in Alliance...

Influencer Laticia Rolle on stepping up her approach to aging.

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will present more than 20 abstracts, including one late-breaking presentation during the 2023 American...

/PRNewswire/ -- In honor of International Womens Day, Allergan Aesthetics, an AbbVie company (NYSE: ABBV) today announced that BOTOX® Cosmetic is partnering...